
Naltrexone Hydrochloride + Bupropion Hydrochloride Er Tablets Suppliers & Bulk Manufacturers
Available Forms: ER tablets
Available Strengths: 8 mg naltrexone hydrochloride / 90 mg bupropion hydrochloride
Reference Brands: Contrave(US & EU)
Category: Weight Loss drugs
naltrexone hydrochloride + bupropion hydrochloride ER tablets is available in ER tablets and strengths such as 8 mg naltrexone hydrochloride / 90 mg bupropion hydrochloride. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, naltrexone hydrochloride + bupropion hydrochloride ER tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
naltrexone hydrochloride + bupropion hydrochloride ER tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Naltrexone hydrochloride and bupropion hydrochloride ER tablets are approved in the US by the FDA and in the EU via EMA for weight management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports swift approval, safe use, and global availability, helping individuals worldwide achieve effective weight loss, appetite control, and metabolic health through high-quality combination therapy supported by regional regulations.
Frequently Asked Questions
Related Products
Metreleptin Injectable Solution
Strength: 11.3 mg/vial
Form: Injectable Solution
Reference Brands: Myalept(US & EU)
View DetailsSetmelanotide Injectable Solution
Strength: 4 mg/mL
Form: Injectable Solution
Reference Brands: Imcivree(Us & EU)
View DetailsOrlistat Capsule
Strength: 120 mg; Alli(60 mg)
Form: Capsules
Reference Brands: Xenical(US & EU)
View DetailsPhentermine/Topiramate Extended-Release Capsules
Strength: 3.75 mg/23 mg, 7.5 mg/46 mg, and 15 mg/92 mg
Form: Capsules
Reference Brands: Qsymia(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers